Clinical trial
A Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients With Rett Syndrome
NCT03941444 is registered in ClinicalTrials.gov with Anavex Life Sciences Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients With Rett Syndrome
- Lead sponsor
- Anavex Life Sciences Corp.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 6, 2019
- Completion date
- September 30, 2021
- Enrollment
- 33 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.